Surface modifications using sugars (e.g., galactose, mannose), peptides (e.g., angiopep-2), or molecules that recognize receptors overexpressed on tumor cells (e.g., LRP1, TfR) enable them to specifically target glioma cells, microglia, or tumor-associated macrophages (TAMs) [38]. This evidence concerns the gene LRP1 and neoplasm.